Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

2011 Russell Varian Prize for Innovation in Nuclear Magnetic Resonance

Published: Friday, September 30, 2011
Last Updated: Friday, September 30, 2011
Bookmark and Share
Agilent Technologies Inc. announces Gareth Alun Morris, professor of physical chemistry at the University of Manchester, as the winner of the 2011 Russell Varian Prize.

The prize is awarded to a researcher based on a single innovative contribution proven to have a significant impact on state-of-the-art nuclear magnetic resonance (NMR) technology. Morris was awarded this year’s prize for his seminal paper, “Enhancement of Nuclear Magnetic Resonance Signals by Polarization Transfer,” published in 1979 in the Journal of the American Chemical Society.

“The Russell Varian Prize is one of the highest accolades that the international NMR community can bestow,” said Morris. “The list of former recipients contains some of the most distinguished names in physics and chemistry, to whom I have looked up throughout my research career, and it is a great and a most unexpected honor to join them.”

The professor’s work provided the basis for the development of insensitive nuclear enhancement by polarization transfer (INEPT), which was originally devised for signal enhancement in liquid state NMR of insensitive nuclei such as carbon-13 and nitrogen-15, by broadband polarization transfer from proton spins. Since its inception, INEPT has evolved into a major component of modern multidimensional NMR techniques, with applications in liquids, liquid crystals and solids. The impact of INEPT has made it an indispensable component of the NMR toolkit.
Morris’s contributions to the knowledge of NMR techniques include more than 180 publications on the topic, and his laboratory continues to refine NMR methods to assist researchers in the fields of chemistry, biochemistry and medicine.

“We are pleased to recognize professor Morris for his significant scientific contributions to the field of NMR, enabling scientists in laboratories around the world to improve the intensity of signals for their chemical and biochemical analysis,” said Regina Schuck, Ph.D., general manager of Agilent’s Research Products Division.

The Russell Varian prize honors the memory of the pioneer behind the first commercial nuclear magnetic resonance spectrometers and co-founder of Varian Associates. The company was later purchased by Agilent.

“The Russell Varian Prize has a long tradition of recognizing the best innovators and researchers in NMR,” said Schuck. “Now a part of Agilent Technologies, we look forward to continuing the tradition of recognizing the top researchers around the world.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent Names CNAG as Certified Provider of Target-Enrichment Services
Centro Nacional de Análisis Genómico (CNAG) in Barcelona is one of Europe’s leading genome analysis centers.
Monday, February 23, 2015
Agilent to Close NMR Business
The announcement is part of Agilent's strategy to address the business shortfalls of its Research Products Division.
Wednesday, October 15, 2014
Agilent Technologies, University of Toronto to Collaborate on Metabolomics MRM Library-Software Solution
Scientists will be provided with a robust LC/MS solution to accelerate cell biology, disease research.
Tuesday, September 30, 2014
Agilent, Seoul National University to Collaborate on New Research Center
The facility will support new drug development center in the university's college of pharmacy.
Tuesday, May 13, 2014
Agilent Introduces Enhanced Electronic Laboratory Notebook
OpenLAB ELN integrates scientific results from multiple analytical software applications, quickly and easily.
Tuesday, November 19, 2013
Agilent and Daegu Gyeongbuk Institute of Science and Technology Collaborate
Neurometabolomics Center will use Agilent's bio-analytical instruments in research of biomarkers for early detection and diagnosis of brain diseases.
Friday, November 01, 2013
Agilent Combines Its Life Sciences and Diagnostics Businesses
Decision follows Agilent's announcement that it plans to separate the company into two independent publicly traded companies.
Thursday, September 19, 2013
Agilent to Acquire Assets from ABC Instrumentación Analítica
The companies have signed a definitive agreement for Agilent to acquire assets from the privately held Mexican distributor.
Thursday, September 05, 2013
Agilent Reports Third-Quarter Results
Revenues were $1.65 billion for the third fiscal quarter ended July 31, 2013, down 4 percent over one year ago.
Thursday, August 15, 2013
Agilent Technologies Triple Quadrupole ICP-MS Selected for R&D 100 Award
These prestigious awards recognize the 100 most technologically significant products introduced into the marketplace over the past year.
Monday, July 15, 2013
Agilent to Host Forensics Webinar
The webinar, which will be held on June 20, will focus on LC/MS/MS methods for cannabinoid and benzodiazepine quantitation in whole blood samples.
Wednesday, June 05, 2013
Agilent Technologies Opens New X-ray Diffraction Manufacturing Facility
The state-of-the-art facility in Wroclaw, Poland gives Agilent significantly greater manufacturing capacity and enhanced R&D capabilities compared with the company's old facility.
Wednesday, November 21, 2012
Agilent Technologies Reports Fourth-Quarter 2012 Results
Revenues for the fourth fiscal quarter ended October 31, 2012 were $1.77 billion, up 2 percent one year ago.
Tuesday, November 20, 2012
Scientific News
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Diagnostic Test Developed for Enterovirus D68
researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year.
How a Kernel Got Naked and Corn Became King
Ten thousand years ago, a golden grain got naked, brought people together and grew to become one of the top agricultural commodities on the planet.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
New Material Opens Possibilities for Super-Long-Acting Pills
A pH-responsive polymer gel could create swallow able devices, including capsules for ultra-long drug delivery.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!